Three mutational markers (TNFAIP3, BRCA1, ASXL1) of non-responders were found to be shared with the DNA markers from patients with progressive disease in an independent cervical cancer cohort (GEO repository: GSE205247) (Fig. S11A). This evidence concerns the gene TNFAIP3 and cervical carcinoma.